Search

Your search keyword '"Numata, K."' showing total 1,211 results

Search Constraints

Start Over You searched for: Author "Numata, K." Remove constraint Author: "Numata, K."
1,211 results on '"Numata, K."'

Search Results

3. Safety and Efficacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis

4. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

6. Multicenter Retrospective Study of Stereotactic Body Radiotherapy for Patients with Previously Untreated Initial Small Hepatocellular Carcinoma

8. The Gravitational Universe

9. Searches for gravitational waves from known pulsars with S5 LIGO data

10. Search for gravitational-wave bursts associated with gamma-ray bursts using data from LIGO Science Run 5 and Virgo Science Run 1

11. LISA laser head metrology

12. Beating the spin-down limit on gravitational wave emission from the Crab pulsar

13. Parametric instabilities in the LCGT arm cavity

14. Report on the first round of the Mock LISA Data Challenges

15. Systematic measurement of the intrinsic losses in various kinds of bulk fused silica

19. P183 Development of a new simple ultrasound activity score for intestinal Behçet's Disease

20. 73MO Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Final analysis of the prospective, observational REFINE study

21. The Challenges of Measuring Methane from Space with a Lidar

23. 446TiP Randomized phase III study of bi-weekly trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV) vs. FTD/TPI for chemorefractory metastatic colorectal cancer (mCRC): ROBiTS/JCOG2014

24. LISA laser head metrology

25. Technology Readiness Advancement of the Laser Transmitter for the LISA Mission

27. Progress and Plans for a US Laser System for LISA

28. 937P Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD

29. P-61 Relatlimab + nivolumab in patients with advanced hepatocellular carcinoma who are naive to immuno-oncology therapy but progressed on tyrosine kinase inhibitors, a phase 2, randomized, open-label study: RELATIVITY-073

30. Contributor contact details

32. Human-body analogy improves mental rotation performance in people aged 86 to 97 years

37. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs

39. 986P Efficacy of atezolizumab (atezo) + bevacizumab (bev) after disease progression with atezo monotherapy in patients with previously untreated, unresectable hepatocellular carcinoma (HCC)

40. 1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study

41. SO-6 The influence of liver function on the outcomes of phase II trial of sorafenib vs. hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

42. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

46. Randomised efficacy and safety results for atezolizumab (Atezo) + bevacizumab (Bev) in patients (pts) with previously untreated, unresectable hepatocellular carcinoma (HCC)

47. Randomised efficacy and safety results for atezolizumab (Atezo) + bevacizumab (Bev) in patients (pts) with previously untreated, unresectable hepatocellular carcinoma (HCC)

48. Fundamental Limit of 1/f Frequency Noise in Semiconductor Lasers Due to Mechanical Thermal Noise

49. An upper limit on the stochastic gravitational-wave background of cosmological origin

Catalog

Books, media, physical & digital resources